These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15867227)
21. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Villa R; Daidone MG; Motta R; Venturini L; De Marco C; Vannelli A; Kusamura S; Baratti D; Deraco M; Costa A; Reddel RR; Zaffaroni N Clin Cancer Res; 2008 Jul; 14(13):4134-40. PubMed ID: 18593991 [TBL] [Abstract][Full Text] [Related]
22. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762 [TBL] [Abstract][Full Text] [Related]
23. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study. Markaki S; Protopapas A; Milingos S; Lazaris D; Antsaklis A; Michalas S Gynecol Oncol; 2005 Mar; 96(3):860-4. PubMed ID: 15721439 [TBL] [Abstract][Full Text] [Related]
24. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481 [TBL] [Abstract][Full Text] [Related]
25. Malignant pleural mesothelioma: surgical management in 285 patients. Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820 [TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599 [TBL] [Abstract][Full Text] [Related]
27. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226 [TBL] [Abstract][Full Text] [Related]
28. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615 [TBL] [Abstract][Full Text] [Related]
29. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? Point to ponder. Desai S; Kane S; Bharde S; Kulkarni JN; Soman CS Indian J Pathol Microbiol; 2001 Apr; 44(2):159-62. PubMed ID: 11883137 [TBL] [Abstract][Full Text] [Related]
31. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma. Edwards JG; Swinson DE; Jones JL; Waller DA; O'Byrne KJ Lung Cancer; 2006 Dec; 54(3):399-407. PubMed ID: 17049671 [TBL] [Abstract][Full Text] [Related]
32. Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Borczuk AC; Cappellini GC; Kim HK; Hesdorffer M; Taub RN; Powell CA Oncogene; 2007 Jan; 26(4):610-7. PubMed ID: 16862182 [TBL] [Abstract][Full Text] [Related]
33. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Davidson B; Skrede M; Silins I; Shih IeM; Trope CG; Flørenes VA Cancer; 2007 Sep; 110(6):1264-71. PubMed ID: 17647260 [TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231 [TBL] [Abstract][Full Text] [Related]
35. An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry? Salman WD; Eyden B; Shelton D; Howat A; Al-Dawoud A; Twaij Z J Clin Pathol; 2009 Jul; 62(7):651-2. PubMed ID: 19561235 [TBL] [Abstract][Full Text] [Related]